 | Up a level |
Fasshauer, Maria; Schuermann, Gesine; Gebert, Norbert; Bernuth, Horst von; Bullinger, Monika; Goldacker, Sigune; Krueger, Renate; Manzey, Petra; Messner, Stefanie; Renner, Ellen D; Ritterbusch, Henrike; Schauer, Uwe; Schulze, Ilka; Umlauf, Volker; Widmann, Steffi; Baumann, Ulrich (2024). A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents. Immunotherapy, 16(12), pp. 813-819. Taylor & Francis 10.1080/1750743X.2024.2367924
Fasshauer, Maria; Borte, Michael; Bitzenhofer, Michaela; Pausch, Christine; Pittrow, David; Park, Michelle; Gladiator, André; Jandus, Peter (2023). Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases. Advances in therapy, 40(12), pp. 5168-5187. Springer 10.1007/s12325-023-02649-0
Fasshauer, Maria; Schuermann, Gesine; Gebert, Norbert; von Bernuth, Horst; Goldacker, Sigune; Krueger, Renate; Manzey, Petra; Notheis, Gundula; Ritterbusch, Henrike; Schauer, Uwe; Schulze, Ilka; Umlauf, Volker; Widmann, Steffi; Baumann, Ulrich (2021). A structured patient empowerment programme for primary immunodeficiency significantly improves general and health-related quality of life. Central European journal of immunology, 46(2), pp. 244-249. Termedia Publishing House 10.5114/ceji.2021.107088
Fasshauer, Maria; Borte, Michael; Bitzenhofer, Michaela; Pausch, Christine; Pittrow, David; Park, Michelle; Gladiator, André; Jandus, Peter (2022). Real-world utilization, safety and patient experience of 20% subcutaneous immunoglobuin in patients with primary immunodeficiencies: final data from the core study (Unpublished). In: ESID Kongress Gothenburg 2022.
